Other studies reported that cancer cells with developed resistance to chemotherapeutic drugs exhibited extraordinary high levels of TG2 expression compared with the parental cell line from which they were derived [21–24], and downregulation of TG2 expression or inhibition of TG2 enzymatic activity can convert chemoresistance in cancer cells [25, 26]. The gene discussed is TGM2; the disease is cancer.